NeuroMetrix Inc NURO:NASDAQ

RT Quote | NASDAQ | USD
Last | 02/25/21 EST
3.46quote price arrow down-0.35 (-9.19%)
Volume
170,575
52 week range
0.81 - 6.20

...

Loading . . .

KEY STATS

  • Open3.79
  • Day High3.79
  • Day Low3.45
  • Prev Close3.46
  • 52 Week High6.20
  • 52 Week High Date04/14/20
  • 52 Week Low0.81
  • 52 Week Low Date03/18/20
  • Market Cap13.15M
  • Shares Out3.80M
  • 10 Day Average Volume0.36M
  • Dividend-
  • Dividend Yield-
  • Beta2.93
  • 1 Year % Change42.39

RATIOS/PROFITABILITY

  • EPS (TTM)-0.89
  • P/E (TTM)-3.90
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-1.655M
  • ROE (MRQ)-53.80%
  • Revenue (MRQ)7.38M
  • Gross Margin (MRQ)71.15%
  • Net Margin (MRQ)-28.36%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date04/23/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest NeuroMetrix Inc News

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
NeuroMetrix, Inc. is a healthcare company combining bioelectrical and digital medicine to address chronic health conditions, including chronic pain, sleep disorders and diabetes. The Company is engaged in the sale of medical equipment, and consumables and accessories. It has two principal product lines: Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. Its products include ADVANCE NCS/EMG System (the ADVANCE System), Quell, SENSUS...
Shai Gozani M.D. Ph.D.
Chairman
Thomas Higgins
Chief Financial Officer
Address
1000 Winter St
Waltham, MA
02451-1436
United States